US Stock MarketDetailed Quotes

CVEO Civeo

Watchlist
  • 21.500
  • -0.500-2.27%
Close Feb 28 16:00 ET
  • 21.500
  • 0.0000.00%
Post 16:05 ET
293.55MMarket Cap-18.07P/E (TTM)

Civeo Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Civeo Q4 2024 Earnings Date

Currency：USDFeb 27, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
162.57M
150.95M
-11.61M
Miss Est.
-4.82%
-11.62%
-7.14%
EPS
-0.27
-1.10
-0.83
Miss Est.
-117.63%
-171.43%
-302.64%
Analyst Rating
Buy

Feb 28, 2025

Civeo Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 165.612M--
--2025/Q1-- / 150.864M--
Feb 27, 20252024/Q4150.951M / 162.565M--
Oct 30, 20242024/Q3176.338M / 168.755M--
Jul 30, 20242024/Q2188.713M / 172.567M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 165.612M--
--2025/Q1-- / 150.864M--
Feb 27, 20252024/Q4150.951M / 162.565M--
Oct 30, 20242024/Q3176.338M / 168.755M--
Jul 30, 20242024/Q2188.713M / 172.567M--

Unlock Free Earnings Estimates

Civeo Earnings Reports

  • Civeo | 10-K: FY2024 Annual Report

    Feb 27 16:49 ET

  • Civeo | 8-K: Civeo Reports Fourth Quarter and Full Year 2024 Results

    Feb 27 08:56 ET

  • Civeo | 10-Q: Q3 2024 Earnings Report

    Oct 30, 2024 13:47 ET

  • Civeo | 8-K: Civeo Reports Third Quarter 2024 Results

    Oct 30, 2024 09:06 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Cars.com
    CARS
    +9.73%
    Lantheus
    LNTH
    +2.55%
    Halozyme Therapeutics
    HALO
    +2.51%
    DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
    DMZPY
    +2.27%
    Collegium Pharmaceutical
    COLL
    +2.22%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Feb 28, 2025

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data